amantadine has been researched along with atropine in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (45.95) | 18.7374 |
| 1990's | 3 (8.11) | 18.2507 |
| 2000's | 9 (24.32) | 29.6817 |
| 2010's | 7 (18.92) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Dekker, TG; Fourie, TG; Oliver, DW; Snyckers, FO | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Daniel Falcón, H | 1 |
| Borsy, J; Dunai-Kovács, Z; Székely, JI | 1 |
| Bermanzohn, PC; Lipper, S | 1 |
| Onodera, K; Shinoda, H | 1 |
| Gupta, RC; Kadel, WL | 1 |
| Bianchi, C; Tomasi, L | 1 |
| Gressier, H; Malecot, E; Poignant, JC | 1 |
| Costall, B; Naylor, RJ | 1 |
| Shibasaki, H | 1 |
| Dulska, E; Lacki, M; Wolfarth, S | 1 |
| Grossmann, W; Jurna, I; Nell, T; Ruzdić, N | 1 |
| Ahtee, L; Kääriäinen, I; Paasonen, MK | 1 |
| Cates, LA; Cramer, MB; Gallio, RL | 1 |
| Florio, V; Longo, VG | 1 |
| Clark, R; Grelak, RP; Stump, JM; Vernier, VG | 1 |
| Link, F | 1 |
| Manten, A | 1 |
| Fincke, M; Gothóni, P; Lehtinen, M | 1 |
| Ferraz, MR; Santos, R | 1 |
| Adotevi, N; Dabrowska, N; Joshi, S; Kapur, J; Lewczuk, E; Shan, S; Sun, H; Williamson, J | 1 |
2 review(s) available for amantadine and atropine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Parkinson's syndrome. Recent progress in the medical treatment and its pharmacological basis.
Topics: Amantadine; Atropine; Catecholamines; Dihydroxyphenylalanine; Histamine H1 Antagonists; Humans; Imipramine; Parkinson Disease; Tryptophan | 1971 |
35 other study(ies) available for amantadine and atropine
| Article | Year |
|---|---|
Synthesis and biological activity of D3-trishomocubyl-4-amines.
Topics: Animals; Antiparkinson Agents; Bridged-Ring Compounds; Catalepsy; Chemical Phenomena; Chemistry; Male; Mice; Stereoisomerism; Structure-Activity Relationship | 1991 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Collateral effects of antiparkinsonian agents used in psychiatry].
Topics: Amantadine; Antiparkinson Agents; Atropine; Atropine Derivatives; Benztropine; Brain; Histamine H1 Antagonists; Humans; Phenothiazines; Respiration; Scopolamine | 1976 |
The effect of anti-parkinsonian drugs on chlorpromazine-induced depression of operant behaviour.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Atropine; Behavior, Animal; Chlorpromazine; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Phenothiazines; Rats; Trihexyphenidyl | 1976 |
Letter: Electroconvulsive therapy in patients with parkinsonism.
Topics: Amantadine; Atropine; Depression; Diphenhydramine; Electroconvulsive Therapy; Female; Humans; Levodopa; Methohexital; Middle Aged; Parkinson Disease; Succinylcholine; Suicide | 1975 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
Prevention and antagonism of acute carbofuran intoxication by memantine and atropine.
Topics: Acetylcholinesterase; Amantadine; Animals; Atropine; Carbofuran; Carboxylesterase; Carboxylic Ester Hydrolases; Chemical Phenomena; Chemistry; Cholinesterase Inhibitors; Drug Antagonism; Drug Synergism; Insecticides; Male; Memantine; Rats; Rats, Inbred Strains | 1989 |
Central nervous system and autonomic nervous system effects of amantadine and of some standard anti-Parkinson drugs.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Autonomic Nervous System; Body Temperature; Carbachol; Central Nervous System; Dihydroxyphenylalanine; Drug Interactions; Gastrointestinal Motility; Male; Mecamylamine; Mice; Mydriatics; Nicotine; Oxotremorine; Phenothiazines; Pupil; Rats; Trihexyphenidyl | 1973 |
Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat.
Topics: Amantadine; Analgesics, Opioid; Animals; Antiparkinson Agents; Apomorphine; Atropine; Benserazide; Benzyl Compounds; Catatonia; Dextroamphetamine; Dextromoramide; Dihydroxyphenylalanine; Dioxoles; Dose-Response Relationship, Drug; Humans; Male; Morphine; Piperazines; Pyrimidines; Rats; Time Factors; Trihexyphenidyl | 1974 |
Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Atropine; Behavior, Animal; Caudate Nucleus; Dextroamphetamine; Dioxoles; Dopamine; Dopamine Antagonists; Drug Synergism; Haloperidol; Humans; Injections; Male; Methylphenidate; Motor Activity; Nialamide; Piperazines; Pyrimidines; Rats; Stereotyped Behavior; Sulfites | 1974 |
Comparison of the effects of the intranigral injections of cholinomimetics with systemic injections of the dopamine receptor stimulating and blocking agents in the rabbit.
Topics: Acetylcholine; Amantadine; Animals; Apomorphine; Atropine; Caudate Nucleus; Cerebral Cortex; Depression, Chemical; Electrodes, Implanted; Electroencephalography; Hippocampus; Humans; Injections; Locomotion; Methacholine Compounds; Neostigmine; Parasympathomimetics; Rabbits; Receptors, Cholinergic; Spirostans; Stereotyped Behavior; Stimulation, Chemical; Substantia Nigra; Time Factors | 1974 |
The effect of -methyl-p-tyrosine and substantia nigra lesions on spinal motor activity in the rat.
Topics: Action Potentials; Amantadine; Animals; Atropine; Dihydroxyphenylalanine; Electrocoagulation; Electromyography; Hydroxydopamines; Methamphetamine; Methyltyrosines; Microinjections; Motor Activity; Motor Neurons; Rats; Reflex; Spinal Nerves; Substantia Nigra | 1972 |
Effect of nalorphine and antiparkinsonian drugs on methadone-induced rigidity; relation to homovanillic acid content of nucleus caudatus.
Topics: Amantadine; Animals; Atropine; Body Temperature; Brain; Caudate Nucleus; Depression, Chemical; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methadone; Muscle Rigidity; Muscle Tonus; Nalorphine; Parasympatholytics; Phenylacetates; Rats; Serotonin; Spectrometry, Fluorescence; Trihexyphenidyl | 1972 |
Phosphorus--nitrogen compounds. XV. N-1-adamantylphosphoramidic dichloride and dimethyl and diphenyl N-1-adamantylphosphoramidate.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Guinea Pigs; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred Strains; Motor Activity; Organophosphorus Compounds; Oxotremorine; Perphenazine; Spectrophotometry, Infrared; Tremorine | 1973 |
Effects of amantadine and of some synthetic antiparkinsonian drugs on the behavioral response to L-DOPA in mice.
Topics: Amantadine; Amitriptyline; Animals; Antiparkinson Agents; Atropine; Behavior, Animal; Dihydroxyphenylalanine; Diphenhydramine; Drug Synergism; Imipramine; Mice; Orphenadrine; Parasympatholytics; Pargyline; Trihexyphenidyl | 1971 |
Amantadine-dopamine interaction: possible mode of action in Parkinsonism.
Topics: Acetylcholine; Amantadine; Animals; Atropine; Dogs; Dopamine; Neurons; Parkinson Disease; Stimulation, Chemical; Vagotomy | 1970 |
[Chemotherapy of viral diseases].
Topics: Amantadine; Antiviral Agents; Atropine; Biguanides; Humans; Idoxuridine; Scopolamine; Thiosemicarbazones; Virus Diseases | 1967 |
[Chemoprofylaxis of influenza].
Topics: Amantadine; Animals; Antiviral Agents; Atropine; Biguanides; Humans; Influenza, Human; Mice; Scopolamine | 1968 |
Drugs for Parkinson's disease reduce tremor induced by physostigmine.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Biperiden; Bromocriptine; Male; Physostigmine; Pimozide; Rats; Rats, Inbred Strains; Tremor | 1983 |
Amantadine stimulates sexual behavior in male rats.
Topics: Amantadine; Animals; Atropine; Copulation; Cordotomy; Ejaculation; Haloperidol; Male; Penile Erection; Rats; Rats, Wistar; Sexual Behavior, Animal; Stimulation, Chemical | 1995 |
α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Plasticity Sustains Severe, Fatal Status Epilepticus.
Topics: Adamantane; Amantadine; Animals; Atropine; CA1 Region, Hippocampal; Dose-Response Relationship, Drug; Electric Stimulation; Female; Gene Knockdown Techniques; Hippocampus; Male; Mice; Mice, Knockout; Neuronal Plasticity; Receptors, AMPA; Status Epilepticus; Synaptic Transmission | 2020 |